list of glp-1 drugs for weight loss Comparing Ozempic, Wegovy and Other What's the skinny on weight-loss

BPC-157 provides researchers with a consistent tool for exploring peptide behavior in laboratory systems focused on structural and cellular dynamics

Without adequate GSH, the body's antioxidant network functions at reduced capacity

Martnez, M

1 REIMAGINE 2 was a 68-week phase 3 trial evaluating the safety and efficacy of CagriSema in doses 2.4 mg/2.4 mg and 1 mg/1 mg once weekly versus semaglutide 2.4 mg, semaglutide 1 mg, cagrilintide 2.4 mg, and dose-matched placebo in 2,713 adults with T2D inadequately controlled with metformin with or without an SGLT2 inhibitor

lactis V9 alleviated constipation symptoms through regulation of intestinal microbiota, inflammation, and metabolic pathways